A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate safety, tolerability and efficacy of various doses
of STP705 administered as intralesional injection in subjects with cutaneous squamous cell
carcinoma (in situ) skin cancer (isSCC).